Ironwood Pharmaceuticals News Center

Skip to main content. You are now leaving ironwoodpharma.com. This link will take you to. A website to which our privacy policy. Does not apply. You are solely. Responsible for your interactions with that website. Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update. Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea IBS-D in the U.S. Ironwood Progresses sGC Stimulator Platform with Positive Top-Line Phase I Data on IW-1973.

OVERVIEW

The domain news.ironwoodpharma.com presently has an average traffic classification of zero (the lower the more users). We have crawled zero pages within the web site news.ironwoodpharma.com and found fifty-five websites associating themselves with news.ironwoodpharma.com. There are two mass web sites belong to this website.
Links to this site
55
Social Links
2

NEWS.IRONWOODPHARMA.COM TRAFFIC

The domain news.ironwoodpharma.com is seeing alternating levels of traffic all over the year.
Traffic for news.ironwoodpharma.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for news.ironwoodpharma.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for news.ironwoodpharma.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO NEWS.IRONWOODPHARMA.COM

Ironwood Pharmaceuticals, Inc. - Investor Relations

At Ironwood, were focused on delivering differentiated medicines to patients. If we do this efficiently and effectively, we hope to generate outstanding returns for our shareholders, inspiring their continued support so that we can create more medicines and build an enduring pharmaceutical company. These are not small goals, but we believe they represent the best way to maximize long-term value for both patients and shareholders.

Ironwood Pharmaceuticals

You are now leaving ironwoodpharma. You are now leaving ironwoodpharma. This link will take you to. A website to which our privacy policy. Responsible for your interactions with that website. THE ART AND SCIENCE OF MAKING MEDICINES.

WHAT DOES NEWS.IRONWOODPHARMA.COM LOOK LIKE?

Desktop Screenshot of news.ironwoodpharma.com Mobile Screenshot of news.ironwoodpharma.com Tablet Screenshot of news.ironwoodpharma.com

NEWS.IRONWOODPHARMA.COM SERVER

We found that a single root page on news.ironwoodpharma.com took nine hundred and eighty-eight milliseconds to come up. We could not detect a SSL certificate, so therefore our parsers consider this site not secure.
Load time
0.988 sec
SSL
NOT SECURE
IP
23.0.160.10

FAVICON

SITE TITLE

Ironwood Pharmaceuticals News Center

DESCRIPTION

Skip to main content. You are now leaving ironwoodpharma.com. This link will take you to. A website to which our privacy policy. Does not apply. You are solely. Responsible for your interactions with that website. Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update. Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea IBS-D in the U.S. Ironwood Progresses sGC Stimulator Platform with Positive Top-Line Phase I Data on IW-1973.

PARSED CONTENT

The domain has the following in the web page, "You are now leaving ironwoodpharma." I observed that the web site also stated " This link will take you to." They also stated " A website to which our privacy policy. Responsible for your interactions with that website. Ironwood Pharmaceuticals Provides Second Quarter 2015 Investor Update. Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea IBS-D in the U. Ironwood Progresses sGC Stimulator Platform with Positive Top-Line Phase I Data on IW-1973."

SEE OTHER BUSINESSES

KB Home Newsroom

KB HOME FOR THE WIN! KB Home has been named an ENERGY STAR Partner of the Year Sustained Excellence award winner for the fifth consecutive year. Learn more about our ENERGY STAR win here. Designed for the Way You Live.

Kellogg Company News Room - Newsroom

Quotes delayed at least 20 minutes. Social K is your opportunity to dive deeper into important topics including innovation, nutrition, sustainability, diversity, social responsibility and more. Kashi Resets Breakfast Rituals With New Offerings. Kellogg Company Reports Second Quarter 2015 Results, Reaffirms Full-Year Currency-Neutral Comparable Guidance. Kellogg Company, BCTGM Announce New Master Contract Agreement.

INGREDIENTS

4 people globally every day. Learn more about the ingredients we put in our products, including. Brands, to help you make the best choices.

Alienmainen Alienmainen - DeviantArt

Forgot Password or Username? Deviant for 3 Years. Deviant since Jan 25, 2012. This is the place where you can personalize your profile! By moving, adding and personalizing widgets.

Ask-Fernanda Kawaii! is my second name! - DeviantArt

Is my second name! Deviant for 1 Year.